Patrys Limited
Patrys Limited (PAB.AX) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Patrys Limited (PAB.AX), featuring income statements, balance sheets, and cash flow data.
Patrys Limited (PAB.AX) Income Statement & Financial Overview
Review Patrys Limited PAB.AX income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $730461.00 | $724729.00 | $669434.00 | $1.03M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $730461.00 | $724729.00 | $669434.00 | $1.03M |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $1.46M | $1.55M | $972648.00 | $3.16M |
| SG&A Expenses | $791958.00 | $760040.00 | $1.10M | $1.04M |
| Operating Expenses | $2.25M | $2.31M | $2.07M | $4.20M |
| Total Costs & Expenses | $2.25M | $2.31M | $2.07M | $4.20M |
| Interest Income | $0.00 | $48066.00 | $61059.00 | $67737.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $23499.00 | $23503.00 | $23494.00 | $23212.00 |
| EBITDA | -$1.50M | -$1.56M | -$2.01M | -$4.13M |
| EBITDA Ratio | -$2.05 | -$2.16 | -$3.007 | -$3.07 |
| Operating Income | -$1.52M | -$1.59M | -$2.07M | -$4.20M |
| Operating Income Ratio | -$2.08 | -$2.19 | -$3.10 | -$4.09 |
| Other Income/Expenses (Net) | $0.00 | -$676663.00 | -$61059.00 | $67737.00 |
| Income Before Tax | -$1.52M | -$2.26M | -$2.01M | -$4.13M |
| Income Before Tax Ratio | -$2.08 | -$3.12 | -$3.007 | -$4.03 |
| Income Tax Expense | $0.00 | -$676663.00 | -$61059.00 | -$958176.00 |
| Net Income | -$1.52M | -$1.59M | -$1.95M | -$3.17M |
| Net Income Ratio | -$2.08 | -$2.19 | -$2.92 | -$3.09 |
| EPS | -$0.001 | -$0.001 | -$0.001 | -$0.002 |
| Diluted EPS | -$0.001 | -$0.001 | -$0.001 | -$0.002 |
| Weighted Avg Shares Outstanding | $2.06B | $2.06B | $2.04B | $2.06B |
| Weighted Avg Shares Outstanding (Diluted) | $2.06B | $2.06B | $2.04B | $2.06B |
Over the past four quarters, Patrys Limited demonstrated steady revenue growth, increasing from $1.03M in Q4 2023 to $730461.00 in Q2 2025. Operating income reached -$1.52M in Q2 2025, maintaining a consistent -208% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$1.50M, reflecting operational efficiency. Net income rose to -$1.52M, with EPS at -$0.001. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan